DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Villanueva C, Albillos A, Genescà J. et al.
β-Blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
Lancet 2019;
393 (10181): 1597-1608
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.